The BioMEMS Core (BMC) provides know-how and state-of-the-art facilities to biomedical investigators interested in new microfluidic tools.

The MGH BioMEMS Core (BMC) provides

  • consulting to biomedical investigators interested in microfluidic tools,
  • training in microfluidic-specific techniques
  • access to microfabrication infrastructure to trained users
  • microfabrication services for Bio-MEMS device users

Many challenging biomedical problems today cannot be approached with the current technology toolbox.   Microfluidics pushes these limits for applications in clinical medicine, life sciences, and technology. Specifically, BMC focuses on translational activities that advance biomedical research of Mass General-Brigham investigators and creating an environment attractive for industry partners interested in prototype testing and early scale-up efforts.